Zoetis Inc. Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zoetis Inc. shares issued, shares, share-based payment arrangement, before forfeiture for fiscal 2023 was 0.00 shares.
- Zoetis Inc. shares issued, shares, share-based payment arrangement, before forfeiture for fiscal 2022 was 0.00 shares.
- Zoetis Inc. shares issued, shares, share-based payment arrangement, before forfeiture for fiscal 2021 was 0.00 shares.
- Zoetis Inc. shares issued, shares, share-based payment arrangement, before forfeiture for fiscal 2020 was 0.00 shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2025-02-13 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-13 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-13 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-14 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2022-02-15 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2021-02-16 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2020-02-13 | |
| 2016-12-31 | 83.01K shares 10-K · filed 2019-02-14 | |
| 2015-12-31 | 465.96K shares 10-K · filed 2018-02-15 | |
| 2014-12-31 | 104.00K shares 10-K · filed 2017-02-16 | |
| 2013-12-31 | 8.00K shares 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |